3.80 USD
▲+0.30+4.40%
盘后 3.69 +1.37%
2026-08-03
市值
$8.15M
市盈率
—
EPS
-8.22
股息率
—
52 周区间
1.31 – 11.48
成交量
122.07K
Beta
1.29
目标价
7.00
52W 低 1.3152W 高 11.48
价格走势
公司简介
Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. The company’s lead product is AD04, a serotonin-3 antagonist, which is in Phase 3 clinical trials for the treatment of alcohol use disorder. It is also involved in the development of drug candidates for non-opioid pain reduction and other diseases and disorders. The company was founded in 2010 and is based in Glen Allen, Virginia.